GET THE APP

Ex vivo expansion of mesenchymal stem cells for management of lim | 57345
Journal of Clinical and Experimental Ophthalmology

Journal of Clinical and Experimental Ophthalmology
Open Access

ISSN: 2155-9570

Ex vivo expansion of mesenchymal stem cells for management of limbal stem cell deficiency


International Conference on Ophthalmic and Oculoplastic Surgery

May 24-25, 2018 Osaka, Japan

Ayman El-Shiaty, Hala Gabr and Essam Darwish

Cairo University, Egypt

Posters & Accepted Abstracts: J Clin Exp Ophthalmol

Abstract :

Purpose: An intervention case series demonstrating the use of mesenchymal stem cells ex vivo co-cultured with limbal tissue in the management of limbal stem cell deficiency. Setting/Venue: Kasr ElAini Faculty of Medicine, Departments of Ophthalmology and Clinical Pathology, Cairo University, Cairo, Egypt. Methods: Eight eyes of seven patients suffering from limbal stem cell deficiency were treated with mesenchymal stem cells derived from their own bone marrow. The mesenchymal stem cells had been co-cultured with allolimbal tissue and transplanted to the patient limbus after being carried on an amniotic membrane. Results: The stem cell deficiency was improved initially in all patients. Recurrence of stem cell deficiency occurred by different degrees in three patients. The follow up period ranged from 3 to 22 months. Conclusion: Mesenchymal stem cell transplantation may be helpful in management of limbal stem cell deficiency when sufficient limbal stem cells are not available. ayman_elshiaty@yahoo.com

Top